The P.1 variant of the coronavirus that helped drive a devastating wave of infections in Brazil is now the second most reported variant in the US, data from the Centers for Disease Control and Prevention (CDC) show, following an increase in new infections and the spread of the B.1.1 virus. 7 British variants that are contagious are now the dominant strains circulating in the US.
Variant P.1, which has grown rapidly in Brazil, think being more contagious than the original strain of Covid-19 and potentially evading an immune response, had been detected in 28 states as of April 8, CDC data show.
434 cases involving the variant have been reported, making it the second most frequently reported variant for the first time.
Most of the cases were reported in Illinois (93), Florida (87) and Massachusetts (102).
P.1 is by far the second most widely reported variant – the B.1.1.7 virus first identified in the UK – which the CDC says is now dominant variant circulating in the US, recorded nearly 20,000 times in all 50 states.
Brazil is facing a Covid-19 crisis so bad that only one expert be equalized it’s for a nuclear reaction out of control. The country has the second number of deaths after the US and daily deaths rose to over 4,000 a day this week. While multiple variants have been detected in Brazil, officials in the US and UK believe P.1 is a very concern, most likely more contagious and better able to evade the body’s defenses. It has spread rapidly, helped by President Jair Bolsonaro’s continued refusal to put in place lockdown measures to contain the outbreak.
345,000. This is the number of people in Brazil who have died from Covid-19 since the pandemic began, according to data from Johns Hopkins University. It is the second highest death toll in the world after the United States, where more than 560,000 people have died.
ISLAMABAD: Working relations between the top leaders of the Pakistan Muslim League (PML-N) and the PPP have become increasingly strained as former PML-N prime minister Quaid Nawaz Sharif refused to speak to Asif Ali Zardari after the loud speech. the last was in the closed meeting of the PDM party chairman last week.
PDM Chairman Maulana Fazlur Rehman tried hard to criticize the two. He spoke to the two separately the following day of an alliance meeting at which Zardari refused to hand over his resignation from the joint assembly by marching against the government.
Political sources told The News here Sunday that the only contention between the PML-N and the PPP is to resign from the assembly and sit down after the long march. Recent events have also helped deteriorate relations between the two parties. The candidacy of the opposition leader in the Senate and support for the PML-N candidate in the chair Karachi NA-249 where PML-N has fielded Miftah Ismail as its candidate based on prior understanding between PDM member parties.
The PPP also appointed its candidates in the contest against understanding. Former PML-N prime minister and senior vice president Shahid Khaqan Abbasi visited Zardari House on Saturday to gather PPP support for Miftah and meet PPP Chairman Bilawal Bhutto Zardari.
The source said that the PPP leader made no guarantees to the visiting PML-N leader for the vote in Karachi. Instead, he put it off on the pretext of consulting the party before making any decisions. The source said that Shahid Khaqan Abbasi had reported the matter to Quaid Nawaz Sharif and asked for his guidance in this matter.
PDM head Maulana Fazl announced on Sunday that alliance workers will accompany Maryam Nawaz Sharif on Friday when she will appear in front of the NAB regional office in Lahore. Since the announcement came from the platform PDM and PPP are still a part of it. PPP has serious complaints about NAB and takes offense about the implementation of NAB. It is not clear whether the PPP workers and leaders will convey solidarity with Maryam Nawaz Sharif on this occasion.
Maulana Fazl will speak with the PPP leadership about the issue as she understands that the strong participation of PPP workers in groups with Ms Maryam’s convoy will help resolve tensions between the two parties. Sources suggest that Maulana Fazl could dash to Karachi to meet with PPP leaders this week as long as he gets a positive signal from there. He will make other efforts to restore mutual trust between PML-N and PPP supporters. He will try to hold a trilateral conference with Nawaz Sharif and Asif Ali Zardari while in Karachi, the sources added.
Doctors are preparing to be part of a nationwide COVID-19 vaccination program
The Federal Government and the country’s top medical groups say there are 4,500 doctors across the country preparing to be part of the COVID-19 vaccination program.
More than 1,000 doctors will start administering the vaccine from March 22, with many more due to join the program in the weeks following.
The rollout of the COVID-19 vaccination program kicked off at hospitals and elderly care centers across the country, and Health Minister Greg Hunt said the expansion to doctors would help more Australians access the injections in the coming months.
Australian Medical Association Vice President Dr Chris Moy spoke to ABC News Breakfast to discuss the launch:
“So, starting from about two weeks, we’ll be at the starting line where about 4,500 practices have, in fact, been approved in the first phase. And during the first four weeks or so it will be staged until launch. Initially, given a relatively small number, because it’s not like the flu vaccine where we have 20 million shots ready to go. “
“They will be given a limited supply at an early stage to start vaccination and start their clinic and to start a vaccination program.”
“Our contact tracing and quarantine have worked effectively, and many of our positive test results have come from students who have been quarantined from across campus,” read a statement from the school. “However, as you will read below, the variants – of which there are at least four concerns – will continue to reach the campus. Although the virus is slightly different, the ways to prevent it are the same: a mask, 6 feet distance, and washing your hands. “
Health experts say Australians can still have confidence in the country’s vaccine strategy, even though the two highly contagious strains of the coronavirus continue to spread rapidly around the world.
The main point:
South Africa has stopped launching the AstraZeneca vaccine
But experts still support the launch in Australia
It is too early to know if we need to change Australia’s vaccination strategy
This is a problem health authorities in Victoria are soon facing, with at least six of the 11 cases linked to the Holiday Inn cluster in Melbourne confirmed as a British variant, with another five being investigated.
La Trobe University Associate Professor in Epidemiology Hassan Vally said the two new strains “outperformed” the original virus.
It’s becoming the dominant strain because it spreads faster, he said.
Dr Vally said the longer the new variants were around and transferred from person to person, the greater their chance of mutating further and creating new strains that were potentially more contagious.
“We’re going to be in a situation where if we don’t eradicate it, and it continues for a while and we don’t control the transmission, it creates more opportunities for further mutations,” he said.
The University of Queensland professor of medicine, Paul Griffin, agrees.
“With a common virus like this, mutations cannot be avoided,” he said.
One small laboratory study suggested the Pfizer vaccine would be effective against the UK and South African variants, but Professor Vally urged caution when interpreting the findings because they were preliminary and from a small number of participants.
“This is a small in-vitro [in the test tube] a study in which serum panels of 20 participants who had previously been immunized with the Pfizer-BioNTech vaccine were tested in the laboratory for activity against non-mutant viral strains as well as engineered mutant viruses, “he said.
Dr Vally said the decision South Africa made “made a lot of sense” because this specific strain had more than 90 percent of cases are genetically sequenced in South Africa and its populations need to be protected from this variant.
The company behind the AstraZeneca jab says it still can protects from severe disease, and Dr Vally is supporting the vaccine rollout in Australia
“The data we have is a very small study, the scope is limited,” he said.
“We have to be careful about how we interpret these findings and not go overboard.
“The most important thing is that it is safe and effective against severe disease.”
Professor Paul Griffin said he would “definitely not ignore” AstraZeneca based on the research and he still believes in Australia’s vaccine plan.
“It is thought to be reasonable that this vaccine could still have a meaningful impact in preventing hospitalizations and deaths from this strain, which is obviously still very important,” he said.
And it’s not only AstraZeneca that has been less effective against the South African variant; everything is less effective, including files Novavax Vaccine.
Do we need a COVID-19 booster shot?
Potentially, but it’s too early to know for sure.
Professor Griffin said even if COVID-19 vaccine manufacturers needed to update their vaccines to tackle a new strain, it wouldn’t be a long process – but a process that could reverse in weeks or months.
Dr Vally said the current vaccine was most likely the “first generation” of the COVID-19 vaccine.
“We will just keep updating our vaccine,” he said.
How do manufacturers update vaccines?
Professor Raina MacIntyre, head of the biosecurity program at the Kirby Institute at the University of New South Wales, said a meaningful update was needed to adapt the jab to suit mutations in the new strain.
“All vaccines target a specific protein on the surface of the virus,” he said.
“If the protein changes through mutation, the vaccine also needs to be adjusted to match the mutation.
“It’s easy, but faster for mRNA vaccines than traditional vaccines.”
Professor Griffin said he believed it was too early for Australia to change its position regarding one of its vaccine candidates.
“If our TGA approves a vaccine, we can be very confident in its use.”
Dr Vally said while vaccination is one way to stop transmission of the virus, it is not the only tool in the toolbox.
“Obviously any new variant will be a challenge for us, but if you don’t have viral transmission, no matter what dominant strain if we control transmission using other tools at our disposal … vaccination is one of those tools,” he said.